Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05636137 Enrolling by invitation - Healthy Clinical Trials

Analysis of Internet Addiction, Musculoskeletal Pain and Body Awareness in High School Students

Start date: November 24, 2022
Phase:
Study type: Observational

The study will investigate internet addiction, musculoskeletal pain and body awareness in high school students.

NCT ID: NCT05633862 Not yet recruiting - Healthy Clinical Trials

A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body

Start date: December 30, 2022
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate pharmacokinetics, safety and tolerability of BI 1015550 in Chinese healthy male and female subjects following administration of single doses.

NCT ID: NCT05633745 Not yet recruiting - Healthy Clinical Trials

A Study to Assess NEU-723 in Healthy Participants

Start date: January 16, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose (SAD), multiple ascending dose (MAD), of orally administered NEU-723 in healthy subjects.

NCT ID: NCT05633238 Enrolling by invitation - Healthy Clinical Trials

SSVEP and Distractor Processing During Visual Search

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

In this line of research, the researchers are utilizing an EEG measure of repeated visual stimulation, the Steady-State Visually Evoked Potential (SSVEP) to examine processing of target and distractor information during visual search. This is a basic science study.

NCT ID: NCT05632575 Not yet recruiting - Healthy Clinical Trials

The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South

Start date: March 2023
Phase: Early Phase 1
Study type: Interventional

Young Latina women face significant barriers to sexual health and healthcare access, particularly in emerging Latino states like Alabama. The goals of the proposed study are to develop and examine the feasibility of an innovative, scalable mHealth, "safe space" intervention for Young Latina Women (YLW) in Alabama (AL) and to stimulate the conduct of behavioral research at the University of Alabama. This work is consistent with the National Institute of Nursing Research's goals of "Enhancing wellness by understanding the physical, behavioral, cultural and environmental influences on health status and developing culturally tailored interventions to prevent illness and promote health" and "Using innovative technologies to develop novel interventions that deliver personalized care and real-time health information to patients, families and healthcare providers".

NCT ID: NCT05632406 Not yet recruiting - Healthy Clinical Trials

Breathing & Blood Pressure

Start date: September 1, 2023
Phase:
Study type: Observational

The purpose of this study is to determine the effect of obesity on cardiovascular responses during various breathing maneuvers.

NCT ID: NCT05632393 Not yet recruiting - Healthy Clinical Trials

A Study to Measure Daridorexant in Breast Milk of Healthy Lactating Women

Start date: November 30, 2022
Phase: Phase 1
Study type: Interventional

A study to measure daridorexant in breast milk of healthy lactating women

NCT ID: NCT05631119 Not yet recruiting - Healthy Clinical Trials

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

SAN-08961
Start date: December 15, 2022
Phase:
Study type: Observational [Patient Registry]

The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.

NCT ID: NCT05630287 Completed - Healthy Clinical Trials

A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants

Start date: August 1, 2018
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to compare the amount of selpercatinib that gets into the blood stream and how long it takes the body to get rid of it and also to assess the pharmacokinetics (PK), metabolism, and routes and extent of elimination of selpercatinib in healthy male participants. The study will last up to 59 days (Part 1) or 46 days (Part 2) including screening and 7-day safety follow-up.

NCT ID: NCT05630274 Completed - Healthy Clinical Trials

A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants

Start date: April 16, 2019
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to assess the effect of Selpercatinib (LY3527723) on the heart rate-corrected QT (QTc) interval. The study will last up to 41 days.